Factors affecting the concentration of colistin in the blood of bone marrow transplant patients.
Not Applicable
- Conditions
- Health Condition 1: null- Bone marrow transplant patientsHealth Condition 2: C948- Other specified leukemias
- Registration Number
- CTRI/2018/05/014203
- Lead Sponsor
- TRAC TMC Research Administrative Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing to give written informed consent.
Bone Marrow Transplantation patients being initiated on Colistin.
Neutropenic patients whose blood culture is showing sensitive to colistin (or)
Neutropenic patients not responding to Meropenem defined as hemodynamically
unstable or patients with persistent fever even after 24-48 hrs of start of
meropenem.
ECOG PS <= 2
Exclusion Criteria
History of allergy to Colistin
Patients with active HIV infection or serology positive for HBV, HCV, HAV.
Any other medical condition or any abnormal lab findings which may adversely affect
the patient, based on physician discretion.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method